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Measurement of an antigenic response to the aphthovirus infection-associated antigen (VIA), the viral RNA polymerase
3Dpol, is frequently used as a discriminating assay for the extent of viral replication in animals. In practice, animals
seropositive for VIA are assumed to have been exposed to live virus, although in fact it is suspected that endogenous 3Dpol
in commercial inactivated vaccines may occasionally stimulate analogous responses and result in false-positive tests for
virus exposure. Cardiovirus infections in mice produce similar anti-VIA antibodies, and in view of recently developed
attenuated Mengo vaccines and live Mengo vectors, these VIA responses are also under investigation as potential correlates
of vaccine efficacy. We have purified recombinant Mengo 3Dpol, developed monoclonal antibodies to the protein, and used
these reagents in highly sensitive Western blot assays to quantify the levels of endogenous 3Dpol in Mengo and encepha-
lomyocarditis virus (EMCV) preparations. The presence of 3Dpol was detected at all stages of standard vaccine purification
procedures, including materials purified by CsCl. Clarified suspensions of Mengo- or encephalomyocarditis virus-infected
HeLa cells were found to contain very high quantities of 3Dpol, averaging ;1.2–1.5 mg of protein/mg of virus. Pelleting through
30% sucrose or purification by CsCl removed much of this material, but even these samples retained ;0.2–0.4 ng of 3Dpol/mg
virus. These ratios represent ;1 3Dpol molecule/20 virus particles in the most highly purified materials and probably indicate
that 3Dpol is a contaminant on the particle surface rather than an intrinsically packaged molecule. In clarified cell lysates,
which are commonly used as vaccine inocula, the protein to virus ratio was ;210:1, a level that could represent serious
contamination problems for future VIA detection if such inocula are used without further purification. © 1999 Academic Press
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The use of nonstructural viral proteins as serological
ndicators of viral replication is a common practice in
ield assays that attempt to discriminate among animals
xposed to live virus. Animals immunized with inacti-
ated vaccines against foot-and-mouth disease virus
FMDV) and its associated nonstructural proteins repre-
ent a well studied system in this regard (Bergmann et
l., 1993; Berger et al., 1990; Neitzert et al., 1991; De
iego et al., 1997; Meyer et al., 1997; Lubroth and Brown,
995; Rodriguez et al., 1994; Silberstein et al., 1997;
minev et al., 1997). One particular virus-induced anti-
en, VIA, has been identified as the viral polymerase
Dpol, a highly immunogenic 52-kDa protein produced
nly during active virus replication in cells or animals
Cowan and Graves, 1966; Bergmann et al., 1993;
cVicar and Sutmoller, 1970; Berger et al., 1990; So-
ensen et al., 1998; O’Donnell et al., 1998). Recently,
owever, 3Dpol was also detected as a minor component
f FMD virion preparations, and therefore, it is highly
ikely the protein is occasionally formulated as an inad-
ertent component of the vaccines prepared from these
1 To whom reprint requests should be addressed at 433 Babcock
arive. Fax: (608) 262-6690. E-mail: vfrolov@biochem.wisc.edu.
042-6822/99 $30.00
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148irions (Newman et al., 1994; Newman and Brown, 1997).
his type of contamination, whether endogenous or ex-
genous to the virions, may be responsible for the peri-
dic field observation of animals seropositive to 3Dpol
fter inoculation with inactivated vaccines, under condi-
ions where the animals have never had contact with live
MDV (Pinto and Garland, 1979; Alonso et al., 1988;
awe and Pinto, 1978).
The cardioviruses are a genus of picornaviruses
losely related to the aphthoviruses, and they too pro-
uce a VIA response in convalescent animals after ex-
osure to live virus. During the past few years, multiple
enetically engineered strains of cardioviruses have
een created, including several highly attenuated vari-
nts of Mengo virus and encephalomyocarditis virus
EMCV), that have excellent live vaccine potential (Duke
t al., 1990; Palmenberg and Osorio, 1994; Osorio et al.,
996b). The efficacy of these attenuated strains as vac-
ines against EMCV infection has been demonstrated
epeatedly in many species of mammals, including mice,
igs, and primates (Osorio et al., 1996a; Backues et al.,
999). The Mengo vaccine strains have been additionally
arnessed by genetically coercing them into carrying
arge chimeric heterologous epitopes or antigens from
oreign pathogens (HIV-1, rabies, LCMV, and others) and
elivering them as efficacious immunogens (Altmeyer et
l., 1994, 1995) after virus inoculation. Given the manner
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149CARDIOVIRUS 3Dpoln which the VIA antigen of FMDV has been used as a
irus replication indicator in convalescent animals, it has
een speculated that the parallel antigenic response to
Dpol in Mengo-vaccinated animals might also provide
owerful predictive data for the correlate expression of a
ardioviral vector’s extra chimeric genes, and perhaps
ven serve as a sensitive protein expression indicator for
ll nonstructural proteins, independent of the vector’s
bility to induce Mengo-neutralizing antibodies. An ex-
erimental constraint to this approach has been that the
evels of endogenous 3Dpol in virus preparations used for
ardiovirus immunizations have never been precisely
uantified, either for purified virus preparations or for the
ruder, cell-lysate fractions that are typically used as
accines.
We have reported the cloning and expression of re-
ombinant Mengo 3Dpol and the isolation of a panel of
onoclonal antibodies (mAbs) directed against this pro-
ein (Duque and Palmenberg, 1996). The availability of
hese reagents presented an opportunity for the charac-
erization of 3Dpol antigenic responses as replication in-
icators for cardiovirus infection. As a first step, we
eveloped a highly sensitive Western blot assay to mea-
ure the abundance of 3Dpol in virus preparations. The
ssay permitted examination of crude virus-cell lysates
s well as virus fractions purified by sucrose pelleting
nd isopycnic banding and a relative evaluation of pro-
edures for the removal of 3Dpol in samples destined for
accine use. Another assay application was a quantita-
FIG. 1. Detection of 3Dpol in fractions from infected HeLa cells. HeL
ncubated at 37°C under 5% CO2. At 2-h intervals p.i., plates were r
upernatants) were collected (;1 ml). Then plates were exposed to fre
entrifugation for 10 min at 2000g. The membranous pellets were disso
olumes (20 ml/lane) of the supernatants (A) and the membrane fractio
see Materials and Methods). Release of virus into the growth medium
ere lysed by freezing–thawing (three times), and samples of this ly
ractionated and assayed in an identical manner.ive determination of whether most 3Dpol could indeed be pemoved from cardiovirus preparations and an assess-
ent of whether any remaining protein was likely to be
ndogenous or exogenous to the particles themselves.
RESULTS
Dpol in infected cells and crude lysates
Membrane fractions of infected HeLa cells (Fig. 1B)
how the earliest appearance of 3Dpol and other 3D
recursors (e.g., 3CD, 3ABCD) between 2 and 4 h postin-
ection (p.i.). The total level of 3Dpol rose progressively
uring the course of infection, with the appearance of
Dpol-related degradation products (3D*) peaking at 8 h
.i., when most of the cells exhibited pronounced cyto-
athic effects (CPE), as is typical of cardiovirus infection.
nterestingly, even at the terminal stages of infection (.6
p.i.), a significant fraction of the 3Dpol material associ-
ted with membranes was still in the precursor form of
ABCD or 3CD, and these proteins remained unproc-
ssed by viral protease 3Cpro, even as the cells began to
yse.
The release of infectious virus into the medium corre-
ated with the lysis of cells (Fig. 1A), as there was a
ignificant increase in supernatant titer [from ,1.6 to 7.0
og plaque-forming units (PFU)/ml], between 4 and 6 h
.i. By the 6-h time point, and all times thereafter, 3Dpol
as detectable in steadily increasing quantities in the
edium as well. The 3Dpol precursors were rarely ob-
erved in the supernatant, indicating these proteins were
onolayers were grown in 10-ml plates, infected with vMC0, and then
d from the incubator, and samples of the growth medium (cell-free
hawing (three times), and lysed cells were collected and subjected to
1 M NaCl containing 10% of SDS (1% the volume of initial lysate). Equal
were fractionated on SDS–PAGE and assayed for 3Dpol mAb reactivity
uantified by plaque assay. The cells from an additional plate (8 h p.i.)
0 ml) before (C) and after (D) clarification for 10 min at 2000g werea cell m
emove
ezing-t
lved in
ns (B)
was q
sate (2redominantly membrane associated, even after cell ly-
s
e
l
a
m
d
o
3
F
v
g
a
a
c
(
e
a
(
f
w
t
v
c
f
r
e
t
m
3
d
s
t
a
s
t
i
t
t
b
a
s
t
a
t
b
S
(
m
v
P
w
s
2
w
a
a
150 FROLOV, DUQUE, AND PALMENBERGis. This partitioning of 3Dpol precursors is especially
vident in Figs. 1C and 1D. The starting sample (Fig. 1C,
ysed cells plus medium) shows strong bands of 3Dpol
nd 3CD. Clarification by centrifugation (Fig. 1D) re-
oved virtually all of the 3CD, whereas 3Dpol was evenly
istributed in both fractions.
Before further virus purification, it was necessary to
btain a reasonable estimate of the quantity of soluble
Dpol in the crude cell lysates. Samples similar to those in
ig. 1D were prepared for three different viruses: vMC0,
Mwt, and vEC9. These strains are known to have similar
rowth kinetics (Hahn and Palmenberg, 1995; Martin et
l., 1996) and give similar infectious titers (;109.5 PFU/ml)
nd virus yields (;1 mg or 7.1 3 1010 particles/106 HeLa
ells) when propagated under standard conditions
Rueckert and Pallansch, 1981). Virus recovery in our
xperiments was always similar for those strains, usually
veraging ;1.2 mg of purified virions/ml of clarified lysate
data not shown). The samples of crude lysates were
ractionated by SDS–PAGE, and then the soluble 3Dpol
as assayed by Western blot and quantified by reference
o recombinant protein standards (Fig. 2). The average
alue was determined as 1.8 6 0.3 mg of 3Dpol/ml of
larified lysate (n 5 6) for vMC0, 1.4 6 0.2 mg/ml (n 5 4)
or vMwt, and 1.5 6 0.2 mg/ml (n 5 4) for vEC9. Therefore,
egardless of the starting strain of virus, it could be
stimated that crude lysates from infected cells (8 h p.i.)
ypically contained ;1.3 mg of 3Dpol/mg of virus, or ;210
olecules of 3Dpol/virion.
Dpol in virus preparations after sucrose pelleting
The high growth titers of cardioviruses and the uniform
ensity of their particles make it easy to purify virions by
edimentation through sucrose cushions. Done correctly,
his procedure leads to minimum loss of infectivity (,1%)
nd substantial concentration of virus. When crude ly-
ates from vMC0, vMwt, and vEC9 were fractionated in
his manner (Fig. 3), the predominant bands, as visual-
FIG. 2. Quantification of 3Dpol in clarified lysates. HeLa cell monolay
y freezing-thawing (3X), without prior removal of the original medium.
DS-PAGE (2, 1, or 0.5 ml/lane) and assayed for 3Dpol mAb reactivity in W
8, 4, 2, 1, and 0.5 ng/lane) were assayed in parallel.zed by Coomassie staining (10 mg of virus/lane), were phose of viral capsid proteins, 1B, 1C, and 1D. Protein 1A,
he fourth and smallest capsid protein was not retained
y this gel. We estimate that sucrose-pelleted Mengo
nd EMCV were typically concentrated by ;100-fold and
ubstantially purified with regard to cellular proteins by
his single step. Nevertheless, when assayed by Western
nalysis, the sucrose-pelleted samples were still found
o contain detectable quantities of 3Dpol (Figs. 4A and
re infected with vMC0, vMwt, or vEC9. At 8 h p.i., the cells were lysed
arification for 10 min at 2000 g, the suspensions were fractionated on
analyses (Methods). Reference samples containing recombinant 3Dpol
FIG. 3. Virus purification by sucrose pelleting. Infected HeLa cell
onolayers were harvested at 8 h p.i., the lysates were clarified, and
irus purified by pelleting through 30% sucrose cushions (Methods).
elleted virus samples (10 mg, as recovered from 108 infected cells)
ere fractionated by SDS-PAGE (9%) and visualized by Coomassie
taining (A): lane 1, vMC0-infected cell lysate (from ;5x10
6 cells); lane
, vMC0 virus; lane 3, vMwt virus; lane 4, vEC9 virus. Similar samples
ere fractionated by SDS-PAGE (9%) and visualized after Western blot
nalysis using polyclonal antibodies against Mengo capsid proteins,
nd ECL detection methods (B): lane 5, vMC0-infected cell extract (8 hers we
After cl
estern.i.); lane 6, vMC0 virus (50 ng).
4
p
i
t
f
D
v
r
s
3
c
s
r
t
f
l
a
1
f
r
r
t
w
w
s
i
C
n
c
s
w
w
s
p
t
o
r
r
i
b
c
w
c
l
m
s
w
3
f
t
n
t
i
t
3
p
a
S
m
C
t
A
e
s
m
6
c
151CARDIOVIRUS 3DpolB). Multiple independent isolations with separately pre-
ared virus stocks confirmed that a small, but reproduc-
ble fraction of this protein was always associated with
he pelleted material. For vMC0, the pelleted 3D
pol was
ound at a ratio of 0.5 6 0.3 ng/mg of virus (n 5 19).
eterminations with vMwt [0.2 6 0.1 ng/mg (n 5 10)] and
EC9 strains [0.3 6 0.1 ng/mg (n 5 4)] showed similar
atios. These values indicate that after our standard
edimentation conditions, there were 3–8% as many
Dpol molecules as virions, and .99.9% of 3Dpol from the
rude fractions had been removed by this purification
tep.
Parallel Western blot using high-titer (ascites) mAbs
aised against 3Cpro, another Mengo nonstructural pro-
ein, readily detected this protein in the membranous
ractions from lysed cells (Fig. 4D, lane 7), but in clarified
ysates, the molecular content of 3Cpro was barely detect-
ble (lane 6), with an estimated concentration at least
FIG. 4. Quantification of 3Dpol and 3Cpro in virus samples. (A) Three
ndependent samples of vMC0 (5 mg each) were isolated by pelleting
hrough sucrose cushions, fractionated on SDS-PAGE and assayed for
Dpol mAb reactivity in Western analyses (Methods). Reference sam-
les of recombinant 3Dpol were assayed in parallel. (B) Viruses vMwt
nd vEC9 (5 mg each) were assayed for 3D
pol mAb reactivity as in A. (C)
ucrose-pelleted virus samples were banded in CsCl, then assayed (5
g each) for 3Dpol mAb reactivity as in A. Note, for vMC0 and vMwt, the
sCl was removed by second sucrose pelleting step before gel frac-
ionation; for vEC9, the CsCl was removed by Centricon filtration. (D)
ssays for 3Cpro mAb reactivity in Western analysis: lanes 1–2, refer-
nce samples of recombinant 3Cpro (8 and 4 ng); lanes 3–4, clarified
upernatant and membrane fractions from uninfected HeLa cells (20
l); lane 5, sucrose pelleted vMC0 virus prepared as in A (5 mg); lanes
–7, clarified lysate and membrane fractions from vMC0 infected HeLa
ells (20 ml).0-fold lower than 3Dpol. That highly sensitive mAbs mailed to detect any immunogenic quantity of 3Cpro or
elated nonstructural precursors in purified virus prepa-
ations (line 5) suggests the above measured 3Dpol con-
ent was unique to the protein, and perhaps selective.
However, it was not immediately clear from the data
hether the 3Dpol remaining in the virus preparations
as intrinsically complexed with pelleted virions or con-
isted of residual contaminant material. To test the latter
dea, we performed size exclusion experiments with
entricon concentrators (not shown) and found that
early 95% of 3Dpol in a typical clarified lysate existed as
omplexes or aggregates of .100 kDa. Moreover, when
upernatant fractions from above the sucrose cushions
ere analyzed after standard centrifugation (4 h), there
as a consistent enrichment of 3Dpol material at the
ucrose interface, indicating a sizable fraction of this
rotein did not behave like 52-kDa monomers (Fig. 5A). If
he sucrose sedimentation step was repeated (for an-
ther 24 h), there was a noticeable increase in antibody-
eactive material (3Dpol and degradation products) in the
esultant pellets, representing ;10–20% of the total 3Dpol
n the sample (Fig. 5B). Much of the 3Dpol (.99.9%) could
e removed from virus preparations by the single su-
rose cushion pelleting step if the sedimentation time
as properly controlled (4 h), but the data imply that the
FIG. 5. Distribution of 3Dpol during sucrose fractionation. (A) HeLa
ell monolayers, infected with vMC0, were harvested at 8 h p.i., the
ysates were clarified, layered over 30% sucrose cushions, then sedi-
ented for 4 h (Methods). Samples of the starting lysate (SL), the
upernatant portion of the gradient (S), and the sucrose interface (I)
ere fractionated on SDS-PAGE and assayed for reactivity to mAbs to
Dpol in Western analyses. (B) The remainder of the supernatant portion
rom the first gradient (S), was layered over a fresh sucrose cushion,
hen sedimented for an additional 24 h (28000 rpm, SW28 rotor). The
ew supernatant (S*), and pellet fractions (P), resuspended in PBS (1%
he volume of the initial supernatant), were assayed for reactivity to
Abs against 3Dpol as in A.
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152 FROLOV, DUQUE, AND PALMENBERGesidual 3Dpol in the pellet fractions was probably from
igh-molecular-weight contaminants (aggregates or
omplexes) rather than an integral viral component.
Dpol in virus preparations after CsCl sedimentation
Cardioviruses undergo a biphasic pH lability in the
resence of halide ions, and thus isopycnic sedimenta-
ion in CsCl is not a preferred purification procedure for
ither Mengo or EMCV. Still, CsCl banding is a good
ethod for estimating the tenacity with which protein–
irus complexes are associated, even if the virus is
nactivated, because virions band at a density (1.34 g/ml)
ifferent quite from salt-dissociable protein (1.30 g/ml).
ucrose-pelleted samples of vMC0, vMwt, and vEC9 were
ixed with CsCl and sedimented to equilibrium. After
ollection, the vMC0 and vMwt virus was repelleted
hrough sucrose to remove the CsCl, and the vEC9 virus
as purified with a Centricon concentrator. Because
sCl alone can cause a partial loss of infectivity, the
irus concentration in the pooled fractions were carefully
ssayed in Western blot assays relative to the starting
amples (sucrose pelleted virus), using sera against the
apsid proteins. The fractions were then reassayed by
uantitative Westerns against 3Dpol (Fig. 4C) and found to
ontain this protein at ;0.2 ng/mg of virions. Experimen-
al repetition with all three virus strains was consistent in
hat CsCl-purified materials typically contained 3Dpol at
n average of 0.2 6 0.1 ng/mg of virions, a level only
lightly lower than that in the original sucrose pellets.
DISCUSSION
Characterization of the poly(C)-dependent attenuation
n Mengo provides excellent opportunities to exploit this
accine phenomenon and further coerce the virus, as an
ngineered vector, into carrying and safely delivering
ther heterologous epitopes against other pathogenic
iruses (Altmeyer et al., 1994, 1995). The practical use of
his system for veterinary or medical purposes balances
elicately between achieving maximum viral attenuation
for safety) and allowing sufficient viral replication for
pitope expression. Although it is clear that subcutane-
us immunization of mice with ,100 particles of Mengo
vMC24) is sufficient to induce anti-Mengo protective,
eutralizing antibodies (Osorio et al., 1996b), we also
now that chimeric epitope expression from these same
engo vectors is intrinsically dependent on achieving
ome minimal threshold of viral replication, which may or
ay not correlate with the simultaneous induction of the
engo neutralization response. Mengo neutralizing an-
ibodies, even from the input inoculum of inactivated
irus, are easy to measure and document, but quantifi-
ble molecular correlates for cardiovirus replication in
nimals have never been looked at in a systematic way.
In the closely related FMD virus, the presence or
bsence of a polyclonal antibody response to VIA, the viral 3Dpol protein, has been used worldwide for many
ears as diagnostic evidence of wild-type virus exposure
i.e., replication) (Cowan and Graves, 1966). But even
ere, most previous attempts to specifically document
he association of 3Dpol with picornavirions or vaccines
ave been limited by the sensitivity of available assays,
nd moreover, it has been hard to assess exactly how
he immunogenicity of such endogenous 3Dpol may be
ffected by the contaminant protein concentrations or by
noculum administration routes (e.g., the presence of
djuvants). We have been pursuing these questions for
he cardioviruses by using assays made possible by
ighly purified recombinant protein and monoclonal an-
ibodies, reagents that permit reproducible and accurate
ssessments of picogram quantities of 3Dpol, against
ellular and viral protein backgrounds that are many
housands of times higher.
In 1977, C. W. Bond and H. E. Swim were the first to
eport the appearance of 3Dpol in sucrose-purified Mengo
reparations. They further noted the relative amount of
rotein seemed to correlate with the temperature used
or virus production (Bond and Swim, 1977). When grown
t 31.5°C, a condition that lowers infectious yields, they
easured a 2:1 ratio of 3Dpol to virions, as determined by
14 labeling. Their low-temperature fractions additionally
ontained significant quantities of uncleaved capsid pre-
ursor, 1CD, as might be consistent with incomplete or
oorly formed particles whose maturation was ther-
odependent. Using similar radiolabeling techniques,
hey were unable to detect any 3Dpol or 1CD in standard
irus preparations grown at normal temperatures (37°C).
ur mAb procedures are at least 20–50 times more
ensitive than radiolabeling, and no doubt this is why we
an detect 3Dpol at levels that are only fractionally stoi-
hiometric, even in virus grown at 37°C.
To summarize, our data suggest that neither sucrose
elleting nor purification in CsCl was able to completely
emove 3Dpol from cardiovirus preparations. The crude
irus suspensions commonly used as vaccine inocula,
ere measured at ;210 3Dpol molecules/virion, an as-
onishing value that if formulated within an inactivated
MDV vaccine and administered with adjuvant would
robably cause many false-positive results in standard
IA assays. Our ensuing experimental outcomes mea-
uring the correlate threshold of protein immunogenicity
t these 3Dpol levels, when formulated as live cardiovirus
accines, are to be reported in detail elsewhere (V. G.
rolov, O. Frolova, H. Duque, and A. C. Palmenberg,
anuscript in preparation), but there is little doubt this
uantity could cause serious background detection
roblems for replication-dependent assays. At the same
ime, the 3Dpol found associated with sucrose-purified
engo samples was considerably lower and much less
han stoichiometric (1 3Dpol/20 virions). Assuming a par-
icle to PFU ratio of 50:1, the 3Dpol in a typical dose of live
accine based on such purified virus, would be ,50
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153CARDIOVIRUS 3Dpolg/106 to 107 PFU, an amount that is probably too small
o elicit a detectable immune response, without multiple
noculations. Technically, such “clean” preparations were
asy to achieve, as long as (1) the cell extracts were
reclarified (30 min at 10,000g) before sucrose pelleting,
2) the pelleting step was brief enough (4 h) to prevent
arge 3Dpol aggregates from sedimenting with the virus,
nd (3) care was taken in the washing steps to avoid
ontamination of the virus pellet with the sucrose inter-
ace or supernatant fractions.
It is hard to evaluate whether the 3Dpol remaining after
hese procedures is intrinsic or extrinsic to the particles.
he 1:20 ratio suggests residual exogenous contamina-
ion, perhaps through high-molecular-weight membrane-
ssociated protein or virion complexes. Detergent dis-
uption of samples before electrophoresis never failed to
elease the expected 52-kDa monomers, implying an
onic, rather than covalent, linkage. On the other hand,
ome residual 3Dpol was always associated with virions,
enaciously surviving even CsCl banding. Moreover, that
nly 3Dpol, and not 3Cpro, 3CD, or other P3 precursors,
ere evident in the purified materials suggests a level of
eliberate selectivity, and the possibility of occasional
olymerase encapsidation by accidental or directed
eans, during particle formation. Inside or outside,
henever such virus is used as inoculum, it seems
mportant to remember that capsid proteins are not the
nly included immunogen, and VIA evaluations always
ust be carefully calibrated with this in mind.
MATERIALS AND METHODS
irus stocks
Mengo viruses, vMwt, and vMC0 were grown from
laques that resulted from transfection of HeLa cells with
7 RNA transcripts derived from cDNA plasmids, pMwt
nd pMC0, as described (Duke and Palmenberg, 1989;
almenberg and Osorio, 1994). EMCV vEC9 was grown
nalogously from plasmid pEC9 (Hahn and Palmenberg,
995). To propagate the viruses, cell monolayers (in
0-cm plates) were inoculated at a multiplicity of infec-
ion (m.o.i.) of 100 PFU/cell. After 8 h of incubation at
7°C under 5% CO2, the infected cells were lysed by
hree cycles of freezing and thawing. The cell debris was
emoved by centrifugation for 10 min at 2000g. Superna-
ants (typically 10 ml) were titered in standard plaque
ssays (Rueckert and Pallansch, 1981) and typically av-
raged ;3 3 109 PFU/ml.
irus purification by sedimentation through sucrose
ushion
Supernatants were clarified for 30 min at 10,000g and
hen layered (;14 ml/tube) over a cushion of 30% su-
rose (in 20 mM Tris, pH 7.4, 1 M NaCl, 3.5 ml/tube). After
entrifugation for 4 h at 16°C, at 28,000 rpm in an SW28 (Beckman) rotor (150,000g), the liquid above the cushion
as carefully aspirated. The tubes were refilled with PBS
pH 7.4, 0.15 M NaCl), which was also removed by aspi-
ation, including the top of the sucrose cushion (;0.5 ml).
he PBS wash was repeated twice more. After that, the
emaining sucrose cushion was removed, and the virus
ellets at the bottom of tubes were resuspended in PBS
1% the volume of initial virus suspension) and homoge-
ized in a sintered glass grinder. A final centrifugation (5
in at 10,000g) removed insoluble debris. Quantification
f virus was by OD260, assuming an extinction coefficient
f 7.7 as 1 mg/ml of virus (Rueckert and Pallansch, 1981).
irus purification in a CsCl density gradient
Virus samples (;100 mg, purified by sucrose pelleting)
ere made in 1% bovine albumin (Sigma Chemical Co.,
t. Louis, MO) and 1% mercaptoethanol. Solid CsCl was
dded to a final solvent density of 1.34 g/ml. Isopycnic
entrifugation was for 18 h at 6°C, 45,000 rpm, in an WTi
5.2 rotor. Fractions (0.25 ml) were collected from the
ottom of the tubes and monitored for the presence of
irus by OD260. The peak fractions were pooled, diluted
ith PBS containing 1% bovine albumin and 1% mercap-
oethanol to a final volume of 14 ml, and then pelleted
hrough a sucrose cushion (as above) to remove CsCl. In
ome cases, CsCl was removed from the virus fractions
y filtration using Centricon-100 tubes (low-speed cen-
rifugation, followed by multiple washes with PBS). For all
reparations, the final concentration of virus (in PBS) was
100 mg/ml.
ecombinant Mengo 3Dpol
Mengo 3Dpol was cloned, expressed and isolated, as
xclusion body preparations, as described previously
Duque and Palmenberg, 1996). This material was frac-
ionated by SDS–PAGE (9% gel), and the 3Dpol band was
isualized by KCl (0.25 M), excised, and transferred to
entricon-50 tubes for electroelution and concentration
n an Amicon apparatus. The purified protein was quan-
ified by OD280 absorbency using bovine serum albumin
BSA) standards (extinction coefficient of 0.661 for 1 mg/
l) and also by Lowery’s methods (DC Protein Assay Kit;
io-Red, Hercules, CA).
estern analyses
Virus samples, or reference samples containing de-
ined amounts of recombinant 3Dpol (twofold dilutions,
.25–16 ng/sample), were fractionated on SDS–PAGE (9%
r 12% gels). The proteins were transferred to Immo-
ilon-P membranes (Millipore) with a Genie electro-
horetic blotter (Idea Scientific Co.). The membranes
ere blocked with PBS containing 5% dried milk and
.05% Tween 20. Murine monoclonal antibodies (as-
ites), 3B7 and 10D3, developed against Mengo 3DpolDuque and Palmenberg, 1996), were mixed at a ratio of
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154 FROLOV, DUQUE, AND PALMENBERG:1, diluted in PBS (1:1000) containing 0.1% casein, and
hen reacted with the membranes (1 h, 20°C). The com-
lexes were detected with anti-mouse IgG antibodies
onjugated with horseradish peroxidase (1 h, 20°C). Vi-
ualization of the bands by film was according to the
anufacture’s suggested chemiluminescence protocols
ECL kit; Amersham). Quantification of 3Dpol in the sam-
les was by visual inspection of the resultant film and
omparison of the relative band intensities with those of
he reference samples. Quantification results are pre-
ented as mean values calculated after several experi-
ental repetitions (n). Detection of 3Cpro was carried out
y similar procedures, using purified r3Cpro and murine
Ab (ascite) 6D10 (Hall and Palmenberg, 1996).
Western blot assays for the detection and quantifica-
ion of viral capsid proteins were similar to those for
Dpol, except that polyclonal mouse serum with a Mengo-
eutralizing titer of ;1:12,800 was used as the detection
eagent, and sucrose-pelleted Mengo virus (twofold di-
utions, 25–200 ng according to OD260) was used as the
eference sample.
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